Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Detail)

v3.20.1
Accrued Expenses - Schedule of Accrued Expenses (Detail) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 4,839 $ 5,395
Employee compensation and benefits 1,652 4,174
Professional fees 309 694
Facilities and other 43 383
Total accrued expenses $ 6,843 $ 10,646